Detalhe da pesquisa
1.
Association between treatment-emergent hypertension and survival with lenvatinib treatment for patients with hepatocellular carcinoma in the REFLECT study.
Cancer
; 130(8): 1281-1291, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38261521
2.
Ankle Lead Arthropathy and Systemic Lead Toxicity Secondary to a Gunshot Wound After 49 Years: A Case Report.
J Foot Ankle Surg
; 56(3): 648-652, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28242216
3.
Treatment-emergent antidrug antibodies related to PD-1, PD-L1, or CTLA-4 inhibitors across tumor types: a systematic review.
J Immunother Cancer
; 12(1)2024 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238030
4.
Characterization and Management of Adverse Reactions in Patients With Unresectable Hepatocellular Carcinoma Treated With Lenvatinib.
J Adv Pract Oncol
; 14(7): 598-607, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-38196672
5.
Lenvatinib in patients with unresectable hepatocellular carcinoma who progressed to Child-Pugh B liver function.
Ther Adv Med Oncol
; 14: 17588359221116608, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36051472